Anesthesia for liver transplantation

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 3, 2013, Pages 180-194

  Hall, Timothy H ^a   Dhir, Achal ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

coagulopathy; hemorrhage; intraoperative assessment; monitoring; noncardiac surgery; reperfusion

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN III; APROTININ; BICARBONATE; CALCIUM CHLORIDE; DESFLURANE; DIPHENHYDRAMINE; ESTROGEN; FENTANYL; HEPARIN; ISOFLURANE; MIDAZOLAM; NORADRENALIN; PHENYLEPHRINE; PROPOFOL; PROSTAGLANDIN; RANITIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; ROCURONIUM; SEVOFLURANE; SUXAMETHONIUM; TRANEXAMIC ACID; VASOPRESSIN;

ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; ANESTHESIA; ANESTHESIST; ARTERIAL PH; ASCITES; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CHRONIC LIVER FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; END STAGE LIVER DISEASE; ESOPHAGUS VARICES; EXTUBATION; FULMINANT HEPATIC FAILURE; HEPATIC ENCEPHALOPATHY; HEPATOPULMONARY SYNDROME; HUMAN; HYDROTHORAX; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; METABOLIC DISORDER; MINIMUM LUNG ALVEOLUS CONCENTRATION; NORTH AMERICA; ORGAN DONOR; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POINT OF CARE TESTING; PORTAL HYPERTENSION; PORTOPULMONARY HYPERTENSION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIMARY BILIARY CIRRHOSIS; RENAL REPLACEMENT THERAPY; REPERFUSION; RESPIRATORY TRACT INTUBATION; REVIEW; STOMACH DISEASE; SURVIVAL; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

COAGULOPATHY; HEMORRHAGE; INTRAOPERATIVE ASSESSMENT; MONITORING; NONCARDIAC SURGERY; REPERFUSION;

ANESTHESIA; ANTIFIBRINOLYTIC AGENTS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE CARE; PREOPERATIVE CARE; REPERFUSION;

EID: 84880293171     PISSN: 10892532     EISSN: 19405596     Source Type: Journal    
DOI: 10.1177/1089253213481115     Document Type: Review

References (60)

1. Biancofiore G, Bindi ML, Romanelli AM, et al. Fast track in liver transplantation: 5 years' experience. Eur J Anaesthesiol. 2005 ; 22: 584-590 (Pubitemid 41097860)
2. United Network for Organ Sharing. Fox 26 News: 30th Anniversary Texas Heart Institute Transplant Program. http://www.texasheartinstitute.org/AboutUs/ News/media-room.cfm. Accessed February 20, 2013.
3. Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol. 2012 ; 28: 230-238
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 ; 60: 646-649
5. Ripoli C. The heart in liver transplantation. J Hepatol. 2011 ; 54: 810-822
6. Kotin P, Hall EM. "Cardiac" or congestive cirrhosis of the liver. Am J Pathol. 1951 ; 27: 561-571
7. Moller S, Bendtsen F, Henriksen JH. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scand J Gastroenterol. 2005 ; 40: 491-500 (Pubitemid 40676241)
8. Biancofiore G. Perioperative considerations in patients with cirrhotic cardiomyopathy. Curr Opin Anesthesiol. 2010 ; 23: 128-132
9. Appleton CP, Hurst RT. Reducing coronary artery disease events in liver transplant patients: moving toward identifying the vulnerable patient. Liver Transpl. 2008 ; 14: 1691-1693
10. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996 ; 2: 426-430 (Pubitemid 26386861)
11. Yong CM. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl. 2010 ; 16: 1242-1248
12. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006 ; 98: 178-181 (Pubitemid 43975507)
13. Diedrich DA, Findlay JY, Harrison BA, Rosen CB. Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc. 2008 ; 40: 3554-3557
14. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010 ; 363: 1341-1350
15. Patel S. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol. 2011 ; 108: 1552-1555
16. Xia VW, Taniguchi M, Steadman RH. The changing face of patients presenting for liver transplantation. Curr Opin Anesthesiol. 2008 ; 13: 280-284
17. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anesthesiol. 2010 ; 23: 145-150
18. Safdar Z, Bartolome S, Sussman N. Portopulmonary hypertension: an update. Liver Transpl. 2012 ; 18: 881-891
19. Hemprich U, Papadakos PJ, Lachmann B. Respiratory failure and hypoxemia in the cirrhotic patient including hepatopulmonary syndrome. Curr Opin Anesthesiol. 2010 ; 23: 133-138
20. Murray KF, Carithers RL. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005 ; 41: 1407-1432 (Pubitemid 40770295)
21. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl. 2006 ; 12: S105 - S107
22. Melzer J, Brentjens T. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies. Curr Opin Anesthesiol. 2010 ; 23: 139-144
23. Angeli P, Morando F, Cavallin M, Piano S. Hepatorenal syndrome. Contrib Nephrol. 2011 ; 174: 46-55
24. Douthitt L, Benzinover D, Uemura T. Perioperative use of continuous renal replacement therapy for orthotopic liver transplantation. Transplant Proc. 2012 ; 44: 1314-1317
25. Hoetzel A, Ryan H, Schmidt R. Anesthetic considerations for the patient with liver disease. Curr Opin Anesthesiol. 2012 ; 25: 340-347
26. Wendon J, Lee W. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care. 2008 ; 9: 97-102
27. Warnar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant. 2008 ; 13: 298-303
28. Hannaman MJ, Hevesi ZG. Anesthesia care for liver transplantation. Transplant Rev. 2011 ; 25: 36-43
29. Rahimi RS, Rockey DC. Complications of cirrhosis. Curr Opin Gastroenterol. 2012 ; 28: 223-229
30. Ehtisham JM, Altieri M, Salamé E, Saloux E, Ollivier I, Hamon M. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl. 2010 ; 16: 550-557
31. Vogt DP, Henderson JM, Carey WD. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery. 2002 ; 132: 775-780 (Pubitemid 35247344)
32. Aydinalp A, Bal U, Atar I. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc. 2009 ; 41: 3757-3760
33. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg. 2002 ; 183: 595-599 (Pubitemid 34603437)
34. Benedetti E, Massad MG, Chami Y. Is the presence of surgically treatable coronary artery disease a contraindication to liver transplantation?. Clin Transplant. 1999 ; 13: 59-61 (Pubitemid 29110390)
35. Azarbal B, Poommipanit P, Arbit B. Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation. Liver Transplant. 2011 ; 17: 809-813
36. Keeling AN, Flaherty JD, Davarpanah AH. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown). 2011 ; 12: 460-468
37. Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transplant. 2004 ; 4: 920-927 (Pubitemid 38745591)
38. Marcel RJ, Ramsay MA, Hein HA, et al. Duration of rocuronium-induced neuromuscular block during liver transplantation: a predictor of primary allograft function. Anesth Analg. 1997 ; 84: 870-874 (Pubitemid 27147717)
39. Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North America. 2004 ; 22: 687-711 (Pubitemid 39487173)
40. Bezinover D, Kadry Z, Janicki P. Contemporary anesthesia management for liver transplantation a comparison of American and European methods. Middle East J Anesthesiol. 2011 ; 21: 251-260
41. Burger-Klepp U, Karatosic R, Thum M, et al. Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagogastric varices. Transplantation. 2012 ; 94: 192-196
42. Levi DM, Pararas N, Tzakis AG. Liver transplantation with preservation of the inferior vena cava: lessons learned through 2,000 cases. J Am Coll Surg. 2012 ; 214: 691-699
43. Vieira de, Melo PS, Miranda LE, Batista LL, et al. Orthotopic liver transplantation without venovenous bypass using the conventional and piggyback techniques. Transplant Proc. 2011 ; 43: 1327-1333
44. Fonouni H, Mehrabi A, Soleimani M, Müller SA, Büchler MW, Schmidt J. The need for venovenous bypass in liver transplantation. HPB (Oxford). 2008 ; 10: 106-203
45. Gabrielson GV. Anesthesia for liver transplantation. Semin Cardiothorac Vasc Anesth. 1998 ; 2: 121-130 (Pubitemid 28340863)
46. Shangraw RE, Winter R, Hromco J. Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Anesthesiology. 1994 ; 81: 1127-1138 (Pubitemid 24340369)
47. Ramsay M. The reperfusion syndrome: have we made any progress?. Liver Transpl. 2008 ; 14: 412-414 (Pubitemid 351524392)
48. Paugam-Burtz C, Kavafyan J, Merckx P. Post-reperfusion syndrome during orthotopic liver transplantation for cirrhosis: outcome and predictors. Liver Transpl. 2009 ; 15: 522-529
49. Cheng SS, Berman GW, Merritt GR, et al. The response to methylene blue in patients with severe hypotension during liver transplantation. J Clin Anesth. 2012 ; 24: 324-328
50. Nieman CU, Kramer D. Transplant critical care: standards for intensive care of the patient with liver failure before and after transplantation. Liver Transpl. 2011 ; 17: 485-487
51. Saner FH, Sotirooulos GC, Radtke A. Intensive care unit management of liver transplant patients: a formidable challenge for the intensivist. Transplant Proc. 2008 ; 40: 3206-3208
52. Taner CB, Willingham DL, Bulatao IG. Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation. Liver Transpl. 2012 ; 18: 361-369
53. Gill RQ, Sterling RK. Acute liver failure. J Clin Gastroenterol. 2001 ; 33: 191-198 (Pubitemid 32762887)
54. Du WB, Pan XP, Li LJ. Prognostic models for acute liver failure. Hepatobiliary Pancreat Dis Int. 2010 ; 9: 122-128
55. Florman S, Miller CM. Live donor liver transplantation. Liver Transpl. 2006 ; 12: 499-510
56. Sabate A, Dalmau A, Koo M. Coagulopathy management in liver transplantation. Transplant Proc. 2012 ; 44: 1523-1525
57. Massicotte L, Denault AY, Beaulieu D, et al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplant center. Transplantation. 2012 ; 93: 1276-1281
58. Kang Y. Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation. Liver Transpl Surg. 1997 ; 3: 655-659
59. Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev. 2011 ; (12). CD009052
60. Darwish A. Liver transplant in Jehovah's Witnesses patients. Curr Opin Organ Transplant. 2011 ; 16: 326-330